Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Thalidomide in Mastocytosis

NCT00769587 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire, Amiens as lead sponsor.

NCT NCT00769587
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00769587 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Thalidomide in Mastocytosis
Lead sponsor
Centre Hospitalier Universitaire, Amiens
Phase
Not reported
Overall status
Completed
Start date
June 30, 2007
Completion date
October 31, 2012
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non neoplastic condition, precancerous condition